Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vitespen |
| Trade Name | |
| Synonyms | Oncophage|HSPPC-96 |
| Drug Descriptions |
Oncophage (vitespen) is a cancer vaccine that uses gp96 as an antigen, which may induce immune response against tumor cells expressing gp96 (PMID: 11727524). |
| DrugClasses | |
| CAS Registry Number | 492448-75-6 |
| NCIT ID | C2432 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pembrolizumab + Temozolomide + Vitespen | Pembrolizumab Temozolomide Vitespen | 0 | 1 |
| Vitespen | Vitespen | 0 | 1 |